Satellite Banner
Technology Networks Header
Thursday, April 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New AB SCIEX Mass Spectrometry Solutions
Friday, June 14, 2013
Extensions of SelexION™ Ion Mobility Technology, SWATH™ Acquisition and ProteinPilot™ Software complement accurate mass instrumentation.

Agilent Introduces Advanced Mass Spec Software
Tuesday, June 11, 2013
New applications to optimize food and forensics analyses and biopharmaceutical characterization.

Agilent Demonstrates New Generation of Ion Mobility Technology
Tuesday, June 11, 2013
Collaborators to present analytical findings at ASMS.

Agilent Launches RapidFire 365 High-Throughput Mass Spectrometry System
Tuesday, June 11, 2013
Product provides walkaway mass spectrometric analysis for researchers working on drug discovery, clinical research and forensic toxicology.

Bruker Launches IMPACT HD Mass Spec Providing Exceptional Proteomic Results
Tuesday, June 11, 2013
Bruker’s IMPACT HD sets a new scientific benchmark of well over 8000 protein identifications from whole-proteome analysis, a record-breaking insight into trace species in complex biological samples.

Waters Introduces the SYNAPT G2-Si to its Mass Spectrometer Product Line
Tuesday, June 11, 2013
Instrument is the most advanced ion mobility-enhanced research mass spectrometer.

Thermo Scientific Unveils LC-MS Software to Transform High Performance Mass Spectrometry
Tuesday, June 11, 2013
Company introduces 10 new or updated software packages at ASMS.

Thermo Scientific Introduces New-generation Triple Quadrupole LC-MS Platform
Tuesday, June 11, 2013
New Thermo Scientific TSQ Quantiva LC-MS breaks attogram sensitivity barrier.

Thermo Fisher Scientific Launches World’s First “Tribrid” LC-MS System
Tuesday, June 11, 2013
Transforming life sciences research with revolutionary depth of analysis and usability.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 1041
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv